United States · FDA National Drug Code directory

Bupropion Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 45963-142_4792385c-d346-4e09-be99-3bde69490586
Product NDC: 45963-142
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Bupropion Hydrochloride
Labeler: Actavis Pharma, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20150217
Source listing expiry: 20271231

Source-listed ingredients

BUPROPION HYDROCHLORIDE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-05) · 45963-142-05
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-30) · 45963-142-30
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-90) · 45963-142-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →